Hanne Hawle

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

Manuela Rabaglio, Zijie Sun, Karen N. Price et al. · Annals of Oncology · 2009 · 181 citations · Full text

Breast Oncology, Bone Health, Medicine +8

Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial

Guido Henke, Michael Knauer, Karin Ribi et al. · Trials · 2018 · 140 citations · Full text

Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)

Lucien Perey, Robert Paridaens, Hanne Hawle et al. · Annals of Oncology · 2006 · 134 citations · Full text

Breast Oncology, Sakk 21/00, Medicine +13

Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08)

Thomas Ruhstaller, Peter Thuss‐Patience, Stefanie Hayoz et al. · Annals of Oncology · 2018 · 102 citations · Full text

First-in human, phase 1, dose-escalation pharmacokinetic and pharmacodynamic study of the oral dual PI3K and mTORC1/2 inhibitor PQR309 in patients with advanced solid tumors (SAKK 67/13)

Andreas Wicki, Nicholas F. Brown, Alexandros Xyrafas et al. · European Journal of Cancer · 2018 · 62 citations

Medicine, Pharmacology, Pharmacotherapy +8